iBio Inc. Common Stock (IBIO)
Stock · NASDAQ · Health Care
$1.36as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$1.64
Industry
Biotechnology: Pharmaceutical Preparations
About IBIO
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optim…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 20
- Website
- ibioinc.com/
Fundamentals
- 1-day range
- $1.34$1.42
- Market cap
- $69.05M
- P/E (trailing)
- —
- P/E (forward)
- -2.45
- EPS (trailing)
- $-0.83
- Dividend yield
- —
- Beta
- 1.25
- Avg. volume
- 862.6K
- Dividend pay date
- June 11, 2018
52-week range
$0.7708$3.82
Next earnings: September 27, 2021 · EPS estimate $-20.00confirmed
Forecasts
8 analyst ratings
Buy 93%
Hold 7%
Sell 0%
1-year price forecast
High
$7
+414.7%
Median
$5.5
+304.4%
Low
$4.2
+208.8%
iBio Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- IBIOiBio Inc. Common Stock$1.36▼ 2.86%Market cap $69.05MP/E —$0.7708$3.82
- XBITXBiotech Inc. Common Stock$2.27▼ 0.00%Market cap $69.51MP/E —$2.09$3.59
- INOInovio Pharmaceuticals Inc. Common Stock$1.28▲ 1.59%Market cap $69.62MP/E —$0.56$2.98
- CLNNClene Inc. Common Stock$4.23▼ 5.48%Market cap $68.24MP/E —
- CINGCingulate Inc. Common Stock$5.32▼ 2.21%Market cap $68.02MP/E —$3.16$11.89
- RNTXRein Therapeutics Inc. Common Stock$0.7621▼ 2.67%Market cap $67.45MP/E —$0.694$2.18
- MNOVMedicinova Inc Common Stock$1.44▲ 1.05%Market cap $66.94MP/E —$1.17$1.96
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IBIO iBio Inc. Common Stock | $69.05M | — | $1.36 | ▼ 2.86% | $0.7708$3.82 |
| XBIT XBiotech Inc. Common Stock | $69.51M | — | $2.27 | ▼ 0.00% | $2.09$3.59 |
| INO Inovio Pharmaceuticals Inc. Common Stock | $69.62M | — | $1.28 | ▲ 1.59% | $0.56$2.98 |
| CLNN Clene Inc. Common Stock | $68.24M | — | $4.23 | ▼ 5.48% | |
| CING Cingulate Inc. Common Stock | $68.02M | — | $5.32 | ▼ 2.21% | $3.16$11.89 |
| RNTX Rein Therapeutics Inc. Common Stock | $67.45M | — | $0.7621 | ▼ 2.67% | $0.694$2.18 |
| MNOV Medicinova Inc Common Stock | $66.94M | — | $1.44 | ▲ 1.05% | $1.17$1.96 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →Acquired
541.1K
Disposed
0
- Carr Molly · July 31, 2026 · Grant430.0K
- Stoner Elizabeth · May 18, 2026 · Grant60.0K
- Marc Banjak · March 26, 2026 · Buy1.4K @ $1.76
- Marc Banjak · March 26, 2026 · Buy12.5K @ $1.64
- Felipe Duran · March 19, 2026 · Buy24.8K @ $2.02
- Martin Brenner · March 19, 2026 · Buy12.3K @ $2.02
Institutional Ownership
March 31, 2026
- Total shares held
- 19.22M
- Total value held
- $36.49M
- Institutional holders
- 49
Top holders this quarter
- Unknown3.11M
- Unknown1.95M
- Unknown1.58M
- Unknown1.55M
- Unknown1.30M
- Unknown1.09M
- Unknown1.01M
- Unknown957.1K
- Unknown956.4K
- Unknown904.3K
See the full, filterable feed with live charts on the MarketWall dashboard.